Statistics
Publications
21
Citations
2.7K
H-Index
20
Active since
2005
Ophélia Maertens is an author at Harvard University specializing in medicine, oncology, and molecular oncology.
Publications per year
2005–2020
21
21
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
Joan Montero, Kristopher A. Sarosiek, Joseph D. DeAngelo et al. · Cell · 2015 · 370 citations
Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors
Dalia Ercan, Chunxiao Xu, Masahiko Yanagita et al. · Cancer Discovery · 2012 · 291 citations · Full text
Medicine, Oncology, Pharmacology +17
Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
Thomas De Raedt, Zandra E. Walton, Jessica L. Yecies et al. · Cancer Cell · 2011 · 257 citations · Full text
Medicine, Cancer Biology, Oncology +16
Elucidating Distinct Roles for <i>NF1</i> in Melanomagenesis
Ophélia Maertens, Bryan W. Johnson, Pablo E. Hollstein et al. · Cancer Discovery · 2012 · 248 citations · Full text
1–5 of 21